Elgethun Capital Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Elgethun Capital Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$105,200
-26.2%
4,0000.0%0.03%
-25.6%
Q2 2023$142,640
+38.7%
4,0000.0%0.04%
+30.3%
Q1 2023$102,840
-31.7%
4,0000.0%0.03%
-38.9%
Q4 2022$150,660
+14.1%
4,0000.0%0.05%
+1.9%
Q3 2022$132,000
-5.0%
4,0000.0%0.05%
-1.9%
Q2 2022$139,000
-24.5%
4,0000.0%0.05%
-12.9%
Q1 2022$184,000
-32.4%
4,0000.0%0.06%
-34.7%
Q4 2021$272,000
+8.8%
4,0000.0%0.10%
+10.5%
Q3 2021$250,000
-24.5%
4,0000.0%0.09%
-24.6%
Q2 2021$331,000
-0.3%
4,000
-20.0%
0.11%
-11.6%
Q1 2021$332,000
-13.5%
5,0000.0%0.13%
-21.3%
Q4 2020$384,000
+48.8%
5,000
-16.7%
0.16%
+16.3%
Q3 2020$258,000
-0.4%
6,0000.0%0.14%
-6.6%
Q2 2020$259,000
+49.7%
6,0000.0%0.15%
+57.3%
Q1 2020$173,000
-54.6%
6,0000.0%0.10%
-48.4%
Q4 2019$381,000
+7520.0%
6,000
+100.0%
0.19%
+4550.0%
Q4 2016$5,0003,0000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders